सामग्री पर जाएँ

दवाओं की अंतःक्रिया

Betibeglogene autotemcel + Dolutegravir

गंभीरता: गंभीर

Betibeglogene autotemcel and Dolutegravir: major interaction.

अंतिम अपडेट

केवल स्वास्थ्य पेशेवरों के लिए — मात्र संदर्भ हेतु। यह पृष्ठ संक्षिप्त सारांश है, चिकित्सकीय सलाह नहीं है और आधिकारिक लेबल या नैदानिक निर्णय का विकल्प नहीं है। दवा लिखने या देने से पहले हमेशा जाँच करें।

इस पृष्ठ की नैदानिक सामग्री केवल अंग्रेज़ी में उपलब्ध है।

सारांश

Antiretrovirals can impair the lentiviral transduction needed to manufacture this gene therapy. Dolutegravir exposure during apheresis could reduce product quality.

इस इंटरैक्शन का सरल भाषा में अर्थ

Betibeglogene autotemcel and Dolutegravir can interact in a way that may be serious. Using them together is sometimes necessary, but it needs a deliberate decision by the prescriber, a plan for monitoring, and clear advice on the warning signs to watch for.

साक्ष्य स्तर: Moderate

ऐसा क्यों होता है

Antiretroviral activity inhibits lentiviral vector integration in collected cells.

क्या करें

Discontinue dolutegravir at least one month before mobilization and until all apheresis cycles are completed. Coordinate an interim HIV plan with an infectious disease specialist.

फार्मासिस्ट से क्या पूछें

  • Does the benefit of taking both outweigh the risk in my case?
  • Do I need any blood test, ECG or other check while on both?
  • What early warning signs should I watch for, and what should I do if they appear?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ सदस्यों के लिए

पूरा पेज खोलें

Betibeglogene autotemcel और Dolutegravir की पूरी प्रबंधन सलाह, अतिरिक्त नोट्स, साक्ष्य का विवरण और पूरे पर्चे का इंटरैक्शन चेकर खोलने के लिए खाता बनाएँ और Pro+ ट्रायल शुरू करें।

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

वेब पर Pro+ को 14 दिन मुफ़्त आज़माएँ। कार्ड की ज़रूरत नहीं।

अक्सर पूछे जाने वाले प्रश्न

Can I take Betibeglogene autotemcel with Dolutegravir?

MediHelp rates the interaction as major. Betibeglogene autotemcel and Dolutegravir can interact in a way that may be serious. Using them together is sometimes necessary, but it needs a deliberate decision by the prescriber, a plan for monitoring, and clear advice on the warning signs to watch for. Antiretrovirals can impair the lentiviral transduction needed to manufacture this gene therapy. Dolutegravir exposure during apheresis could reduce product quality.

How serious is the interaction between Betibeglogene autotemcel and Dolutegravir?

MediHelp rates it major, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Discontinue dolutegravir at least one month before mobilization and until all apheresis cycles are completed. Coordinate an interim HIV plan with an infectious disease specialist.

What other medicines interact with Dolutegravir?

MediHelp also lists interactions of Dolutegravir with, for example, Dofetilide, Aluminum hydroxide, Atidarsagene autotemcel. The full list is on the Dolutegravir page.

MediHelp ऐप में पूर्ण मोनोग्राफ़, खुराक और इंटरैक्शन चेकर

MediHelp ऐप में पूरा संदर्भ खोलें, कई दवाओं की अंतःक्रियाएँ जाँचें और खुराक टूल इस्तेमाल करें।

A–Z ब्राउज़ करें · दवाओं की अंतःक्रिया

ऐप पाएँ साइन इन